Join groupH in Amsterdam at EphMRA: 20-22 June, 2017

Join groupH at EphMRA 2017 in Amsterdam between 20-22 June. Erik Holzinger will be chairing several sessions and also co-presenting with Bernd Mühlenweg from Nanobiotix. Their session will explore the benefits of addressing the payer hurdle very early in clinical development, and will focus on sharing ideas and best practice.

“How engaging payers early transformed our clinical development and portfolio planning – a case study” will be presented on Wednesday 21 June at 2.45pm.

If you or your colleagues are also attending EphMRA 2017, we would be very happy to meet up. Please drop us a line to arrange this.

Even if you can’t make it, we would be happy to share our perspectives from the conference, so do get in touch if you are interested in learning more about the topics that are discussed or about groupH’s work

Introducing Joy Mabon and groupH Inc.

groupH is pleased to announce that Joy Mabon has joined our core team.  She has been a valued colleague for a long time, and is now officially one of us.

Joy is a consultant with many years of experience designing and facilitating bespoke strategy workshops to support biopharmaceutical decision-making across a broad range of therapeutic areas. She is based in Toronto, and joins our established East Coast team.

Joy can be contacted on her mobile: 647-273-2609, or via email:

We are also pleased to announce that last year, we took the step of incorporating groupH in the US.  Morris made the move to California to set up groupH Inc., headquartered in San Francisco.

We are looking forward to being able to work more closely with our US clients, expanding our presence in the US, and building the groupH team on both the East and West Coasts.

To find out more about groupH Inc. and how we can help, please contact Morris Paterson directly on 415-969-1986 or via the new US office at 415-445-4623.

We wish Joy and groupH Inc. continued success!